The new permeability pathways and cytosolic pH: Targets for antimalarial agents on Plasmodium falciparum;Nuevas vías de permeabilidad y regulación del ph intracelular como posibles blancos terapéuticos en plasmodium falciparum

Acta Biologica Colombiana

Volumn 13, Issue 2, 2010, Pages 3-21

  López, Mary Luz ^a   Latorre, Cesar Segura ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Antimalarial drugs; Biological membranes; Cytosolic pH; Plasmodium falciparum

Indexed keywords

PLASMODIUM FALCIPARUM; SOLANUM; SOLANUM NUDUM;

EID: 70349668105     PISSN: 0120548X     EISSN: 19001649     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. ALKHALIL A, COHN JV, WAGNER MA, CABRERA JS, RAJAPANDI T, DESAI SA. Plasmodium falciparum likely encodes the principal anion channel on infected human erythrocytes. Blood. 2004;104:4279-4286.
2. ALVAREZ G, PABÓN A, CARMONA J, BLAIR S. Evaluation of clastogenic potential of the antimalarial plant Solanum nudum. Phytother Res. 2004;18:845-848.
3. ARANGO E, LONDONO B, SEGURA C, SOLARTE Y, HERRERA S, SAEZ J, et al. Prevention of sporogony of Plasmodium vivax in Anopheles albimanus by steroids of Solanum nudum Dunal (Solanaceae). Phytother Res. 2006;20:444-447.
4. ATAMNA H, GINSBURG H. Origin of reactive oxygen species in erythrocytes infected with Plasmodium falciparum. Mol Biochem Parasitol. 1993;61:231-241.
5. AYI K, GIRIBALDI G, SKOROKHOD A, SCHWARZER E, PRENDERGAST PT, ARESE P. 16alpha-bromoepiandrosterone, an antimalarial analogue of the hormone dehydroepiandrosterone, enhances phagocytosis of ring stage parasitized erythrocytes: a novel mechanism for antimalarial activity. Antimicrob Agents Chemother. 2002;46:3180-3184.
6. BANNISTER L, MITCHELL G. The ins, outs and roundabouts of malaria. Trends Parasitol. 2003;19:209-213.
7. BAUMEISTER S, ENDERMANN T, CHARPIAN S, NYALWIDHE J, DURANTON C, HUBER S, et al. A biotin derivative blocks parasite induced novel permeation pathways in Plasmodium falciparum-infected erythrocytes. Mol Biochem Parasitol. 2003;132:35-45.
8. BENNETT TN, PATEL J, FERDIG MT, ROEPE PD. Plasmodium falciparum Na(+)/H(+) exchanger activity and quinine resistance. Mol Biochem Parasitol. 2007;153:48-58.
9. BLAIR S, MESA J, CORREA A, CARMONA J, SÁEZ J. Apertura del anillo F de la Diosgenona y actividad antimalárica de los productos de reacción. Rev Colomb Quim. 2001;30:97-107.
10. BLAIR S, MADRIGAL B. Solanaceae. In: BLAIR-TRUJILLO, S, MADRIGAL, B, editors. Plantas antimaláricas de Tumaco: Costa Pacífica Colombiana. Medellín: Editorial Universidad de Antioquia; 2005. p. 266-270.
11. BLANKEMEYER JT, STRINGER BK, RAYBURN JR, BANTLE JA, FRIEDMAN M. Effect of potato alkaloids on membrane potential of frog embryos. J Agric Food Chem. 1992;40:2022-2026.
12. BLANKEMEYER JT, ATHERTON R, FRIEDMAN M. Effect of potato glycoalkaloids a-chaconine and a-solanine on sodium active transport in frog skin. J Agric Food Chem. 1995;43:636-639.
13. BLANKEMEYER JT, MCWILLIAMS ML, RAYBURN JR, WEISSENBERG M, FRIEDMAN M. Developmental toxicology of solamargine and solasonine glycoalkaloids in frog embryos. Food Chem Toxicol. 1998;36:383-389.
14. BOSIA A, GHIGO D, TURRINI F, NISSANI E, PESCARMONA GP, GINSBURG H. Kinetic characterization of Na+/H+ antiport of Plasmodium falciparum membrane. J Cell Physiol. 1993;154:527-534.
15. BRAVO BJ, SAUVAIN M, GIMENEZ TA, BALANZA E, SERANI L, LAPREVOTE O, et al. Trypanocidal withanolides and withanolide glycosides from Dunalia brachyacantha. J Nat Prod. 2001;64:720-725.
16. BRAY PG, SALIBA KJ, DAVIES JD, SPILLER DG, WHITE MR, KIRK K, et al. Distribution of acridine orange fluorescence in Plasmodium falciparum-infected erythrocytes and its implications for the evaluation of digestive vacuole pH. Mol Biochem Parasitol. 2002;119:301-304; discussion 307-309, 311-303.
17. CANIATO R, PURICELLI L. Review: Natural Antimalarial Agents (1995-2001). CRC Crit Rev Plant Sci. 2003;22:79-105.
18. CHATAING B, CONCEPCION JL, LOBATON R, USUBILLAGA A. Inhibition of Trypanosoma cruzi growth in vitro by Solanum alkaloids: a comparison with ketoconazole. Planta Med. 1998;64:31-36.
19. CHOI I, MEGO JL. Purification of Plasmodium falciparum digestive vacuoles and partial characterization of the vacuolar membrane ATPase. Mol Biochem Parasitol. 1988;31:71-78.
20. DANTAS LEITE L, URBINA JA, DE SOUZA W, VOMMARO RC. Selective anti- Toxoplasma gondii activities of azasterols. Int J Antimicrob Agents 2004;23:620-626.
21. DESAI SA, KROGSTAD DJ, MCCLESKEY EW. A nutrient-permeable channel on the intraerythrocytic malaria parasite. Nature. 1993;362:643-646.
22. DESAI SA, BEZRUKOV SM, ZIMMERBERG J. A voltage-dependent channel involved in nutrient uptake by red blood cells infected with the malaria parasite. Nature. 2000;406:1001-1005.
23. DZEKUNOV SM, URSOS LM, ROEPE PD. Digestive vacuolar pH of intact intraerythrocytic P. falciparum either sensitive or resistant to chloroquine. Mol Biochem Parasitol. 2000;110:107-124.
24. ECHEVERRI M, BLAIR S, CARMONA J, PÉREZ P. Effect of Solanum nudum extracts on the liver of mice infected with Plasmodium berghei. Am J Chin Med. 2001;29:477-484.
25. EGEE S, LAPAIX F, DECHERF G, STAINES HM, ELLORY JC, DOERIG C, et al. A stretch-activated anion channel is up-regulated by the malaria parasite Plasmodium falciparum. J Physiol. 2002;542:795-801.
26. FRANCIS SE, SULLIVAN DJ, JR., GOLDBERG DE. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Microbiol. 1997;51:97-123.
27. FREILICH D, FERRIS S, WALLACE M, LEACH L, KALLEN A, FRINCKE J, et al. 16alpha-bromoepiandrosterone, a dehydroepiandrosterone (DHEA) analogue, inhibits Plasmodium falciparum and Plasmodium berghei growth. Am J Trop Med Hyg. 2000;63:280-283.
28. GEARY TG, JENSEN JB, GINSBURG H. Uptake of [3H]chloroquine by drugsensitive and -resistant strains of the human malaria parasite Plasmodium falciparum. Biochem Pharmacol. 1986; 35:3805-3812.
29. GEARY TG, DIVO AD, JENSEN JB, ZANGWILL M, GINSBURG H. Kinetic modelling of the response of Plasmodium falciparum to chloroquine and its experimental testing in vitro. Implications for mechanism of action of and resistance to the drug. Biochem Pharmacol. 1990; 40:685-691.
30. GERO AM, DUNN CG, BROWN DM, PULENTHIRAN K, GOROVITS EL, BAKOS T, et al. New malaria chemotherapy developed by utilization of a unique parasite transport system. Curr Pharm Des. 2003; 9:867-877.
31. GINSBURG H, NISSANI E, KRUGLIAK M. Alkalinization of the food vacuole of malaria parasites by quinoline drugs and alkylamines is not correlated with their antimalarial activity. Biochem Pharmacol. 1989;38:2645-2654.
32. GINSBURG H, FAMIN O, ZHANG J, KRUGLIAK M. Inhibition of glutathionedependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem Pharmacol. 1998;56:1305-1313.
33. GINSBURG H. Abundant proton pumping in Plasmodium falciparum, but why? Trends Parasitol. 2002;18:483-486.
34. GINSBURG H, STEIN WD. The new permeability pathways induced by the malaria parasite in the membrane of the infected erythrocyte: comparison of results using different experimental techniques. J Membr Biol. 2004;197:113-134.
35. GO ML, LIU M, WILAIRAT P, ROSENTHAL PJ, SALIBA KJ, KIRK K. Antiplasmodial chalcones inhibit sorbitol-induced hemolysis of Plasmodium falciparuminfected erythrocytes. Antimicrob Agents Chemother. 2004;48:3241-3245.
36. GRANDMOUGIN FERJANI A, SCHULER MULLER I, HARTMANN MA. Sterol modulation of the plasma membrane H+-ATPase activity from corn roots reconstituted into soybean lipids. Plant Physiol. 1997;113:163-174.
37. HAINES TH. Do sterols reduce proton and sodium leaks through lipid bilayers?. Prog Lipid Res. 2001;40:299-324.
38. HAYNES RK, KRISHNA S. Artemisinins: activities and actions. Microbes Infect. 2004;6:1339-1346.
39. HAYWARD R, SALIBA KJ, KIRK K. The pH of the digestive vacuole of Plasmodium falciparum is not associated with chloroquine resistance. J Cell Sci. 2006;119:1016-1025.
40. HUBER SM, UHLEMANN AC, GAMPER NL, DURANTON C, KREMSNER PG, LANG F. Plasmodium falciparum activates endogenous Cl(-) channels of human erythrocytes by membrane oxidation. Embo J. 2002;21:22-30.
41. HUBER SM, DURANTON C, LANG F. Patch-clamp analysis of the "new permeability pathways" in malaria-infected erythrocytes. Int Rev Cytol. 2005;246:59-134.
42. KANG M, LISK G, HOLLINGWORTH S, BAYLOR SM, DESAI SA. Malaria parasites are rapidly killed by dantrolene derivatives specific for the plasmodial surface anion channel. Mol Pharmacol. 2005;68:34-40.
43. KARCZ SR, HERRMANN VR, COWMAN AF. Cloning and characterization of a vacuolar ATPase A subunit homologue from Plasmodium falciparum. Mol Biochem Parasitol. 1993;58:333-344.
44. KARCZ SR, HERRMANN VR, TROTTEIN F, COWMAN AF. Cloning and characterization of the vacuolar ATPase B subunit from Plasmodium falciparum. Mol Biochem Parasitol. 1994;65:123-133.
45. KAYSER O, KIDERLEN AF, CROFT SL. Natural products as antiparasitic drugs. Parasitol Res. 2003;90(S2):S55-62.
46. KETOMAKI AM, GYLLING H, ANTIKAINEN M, SIIMES MA, MIETTINEN TA. Red cell and plasma plant sterols are related during consumption of plant stanol and sterol ester spreads in children with hypercholesterolemia. J Pediatr. 2003;142:524-531.
47. KEUKENS EA, DE VRIJE T, VAN DEN BOOM C, DE WAARD P, PLASMAN HH, THIEL F, et al. Molecular basis of glycoalkaloid induced membrane disruption. Biochim Biophys Acta. 1995;1240:216-228.
48. KIRK K, HORNER HA, ELFORD BC, ELLORY JC, NEWBOLD CI. Transport of diverse substrates into malaria-infected erythrocytes via a pathway showing functional characteristics of a chloride channel. J Biol Chem. 1994;269:3339-3347.
49. KIRK K, HORNER HA. In search of a selective inhibitor of the induced transport of small solutes in Plasmodium falciparum-infected erythrocytes: effects of arylaminobenzoates. Biochem J. 1995;311(Pt3):761-768.
50. KIRK K. Membrane transport in the malaria-infected erythrocyte. Physiol Rev. 2001;81:495-537.
51. KIRK K. Channels and transporters as drug targets in the Plasmodium-infected erythrocyte. Acta Trop. 2004;89:285-298.
52. KRISHNA S, ECKSTEIN-LUDWIG U, JOET T, UHLEMANN AC, MORIN C, WEBB R, et al. Transport processes in Plasmodium falciparum-infected erythrocytes: potential as new drug targets. Int J Parasitol 2002;32:1567-1573.
53. KROGSTAD DJ, SCHLESINGER PH, GLUZMAN IY. Antimalarials increase vesicle pH in Plasmodium falciparum. J Cell Biol. 1985;101:2302-2309.
54. LI XX, DAVIS B, HARIDAS V, GUTTERMAN JU, COLOMBINI M. Proapoptotic triterpene electrophiles (avicins) form channels in membranes: cholesterol dependence. Biophys J. 2005;88:2577-2584.
55. LINGNAU A, MARGOS G, MAIER WA, SEITZ HM. The effects of hormones on the gametocytogenesis of Plasmodium falciparum in vitro. Appl Parasitol. 1993;34:153-160.
56. LISK G, KANG M, COHN JV, DESAI SA. Specific inhibition of the plasmodial surface anion channel by dantrolene. Eukaryot Cell. 2006;5:1882-1893.
57. LONDONO B, ARANGO E, ZAPATA C, HERRERA S, SAEZ J, BLAIR S, et al. Effect of Solanum nudum Dunal (Solanaceae) steroids on hepatic trophozoites of Plasmodium vivax. Phytother Res. 2006;20:267-273.
58. LÓPEZ ML. Efecto de los esteroles aislados de la planta S. nudum sobre la membrana del glóbulo rojo humano y el desarrollo de P. falciparum. Corporación Ciencias Básicas Biomédicas. Medellín: Universidad de Antioquia; 2005. p. 91.
59. LORENTE SO, RODRIGUES JC, JIMENEZ JIMENEZ C, JOYCE MENEKSE M, RODRIGUES C, CROFT SL, et al. Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis. Antimicrob Agents Chemother. 2004;48:2937-2950.
60. LORIA P, MILLER S, FOLEY M, TILLEY L. Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials. Biochem J. 1999;339(Pt2):363-370.
61. LUO S, MARCHESINI N, MORENO SN, DOCAMPO R. A plant-like vacuolar H(+)-pyrophosphatase in Plasmodium falciparum. FEBS Lett 1999;460:217-220.
62. MAESHIMA M. Tonoplast transportes: Organization and Function. Annu Rev Plant Physiol Plant Mol Biol. 2001;52:469-497.
63. MARCHESINI N, VIEIRA M, LUO S, MORENO SN, DOCAMPO R. A malaria parasite-encoded vacuolar H(+)-ATPase is targeted to the host erythrocyte. J Biol Chem. 2005;280:36841-36847.
64. MASWOSWE SM, PETERS W, WARHURST DC. Corticosteroid stimulation of the growth of Plasmodium falciparum gametocytes in vitro. Ann Trop Med Parasitol. 1985;79:607-616.
65. MCINTOSH MT, DROZDOWICZ YM, LAROIYA K, REA PA, VAIDYA AB. Two classes of plant-like vacuolar-type H(+)-pyrophosphatases in malaria parasites. Mol Biochem Parasitol. 2001;114:183-195.
66. MCINTOSH MT, VAIDYA AB. Vacuolar type H+ pumping pyrophosphatases of parasitic protozoa. Int J Parasitol. 2002;32:1-14.
67. MIKKELSEN RB, TANABE K, WALLACH DF. Membrane potential of Plasmodium-infected erythrocytes. J Cell Biol. 1982;93:685-689.
68. MINPROTECCIÓNSOCIAL. Situación epidemiológica de las enfermedades transmisibles por vectores 2003-2004. Boletín epidemiológico semanal, Semana Epidemiológica No. 8, Sistema de Vigilancia en Salud Pública (SIVIGILA). Bogotá: Instituto Nacional de Salud; 2004.
69. MORIYAMA Y, HAYASHI M, YATSUSHIRO S, YAMAMOTO A. Vacuolar proton pumps in malaria parasite cells. J Bioenerg Biomembr. 2003;35:367-375.
70. NAGAFUJI S, OKABE H, AKAHANE H, ABE F. Trypanocidal constituents in plants 4. Withanolides from the aerial parts of Physalis angulata. Biol Pharm Bull. 2004;27:193-197.
71. NELSON N, HARVEY WR. Vacuolar and plasma membrane protonadenosinetriphosphatases. Physiol Rev. 1999;79:361-385.
72. O'NEILL PM, BRAY PG, HAWLEY SR, WARD SA, PARK BK. 4-Aminoquinolinespast, present, and future: a chemical perspective. Pharmacol Ther. 1998;77:29-58.
73. OMODEO SALE F, BASILICO N, FOLINI M, OLLIARO P, TARAMELLI D. Macrophage populations of different origins have distinct susceptibilities to lipid peroxidation induced by beta-haematin (malaria pigment). FEBS Lett. 1998;433:215-218.
74. OPS/OMS. Informe de la Situación de los Programas Regionales de Malaria en las Américas. Washington: OMS; 2001; Documento CD43/INF/41.
75. PABÓN A, CARMONA J, MAESTRE A, CAMARGO M, BLAIR S. Inhibition of P. falciparum by steroids isolated from Solanum nudum. Phytother Res. 2002;16:59-62.
76. PABÓN A, BLAIR S, CARMONA J, ZULETA M, SÁEZ J. Evaluation of the mutagenicity of antimalarial products isolated from Solanum nudum (Solanaceae). Pharmazie. 2003;58:263-267.
77. RIEL MA, KYLE DE, BHATTACHARJEE AK, MILHOUS WK. Efficacy of proton pump inhibitor drugs against Plasmodium falciparum in vitro and their probable pharmacophores. Antimicrob Agents Chemother. 2002;46:2627-2632.
78. RODDICK JG, RIJNENBERG AI, OSMAN SF. Synergistic interaction between potato glycoalkaloids alpha-solanine and alpha-chaconine in relation to destabilization of cell membranes ecological implications. J Chem Ecol. 1988;14:889-902.
79. ROOS A, BORON WF. Intracellular pH. Physiol Rev. 1981;61:296-434.
80. SÁEZ J, ESPINAL D, BLAIR S, MADRIGAL B, MARTÍNEZ A. Diosgenona natural en fracción de hexano de Solanum nudum (Solanaceae). Química, actualidad y futuro. 1994;4:35-39.
81. SÁEZ J, CARDONA W, ESPINAL D, BLAIR S, MESA J, BOCAR M, et al. Five new steroids from Solanum nudum. Tetrahedron. 1998;54:10771-10778.
82. SAFEUKUI I, MANGOU F, MALVY D, VINCENDEAU P, MOSSALAYI D, HAUMONT G, et al. Plasmodium berghei: dehydroepiandrosterone sulfate reverses chloroquino-resistance in experimental malaria infection; correlation with glucose 6-phosphate dehydrogenase and glutathione synthesis pathway. Biochem Pharmacol. 2004;68:1903-1910.
83. SALIBA KJ, KIRK K. pH regulation in the intracellular malaria parasite, Plasmodium falciparum. H(+) extrusion via a V-type H(+)-ATPase. J Biol Chem. 1999;274:33213-33219.
84. SALIBA KJ, ALLEN RJ, ZISSIS S, BRAY PG, WARD SA, KIRK K. Acidification of the malaria parasite's digestive vacuole by a H+-ATPase and a H+-pyrophosphatase. J Biol Chem. 2003;278:5605-5612.
85. SKINNER-ADAMS T, DAVIS TM. Synergistic in vitro antimalarial activity of omeprazole and quinine. Antimicrob Agents Chemother. 1999;43:1304-1306.
86. STAINES HM, ELLORY JC, KIRK K. Perturbation of the pump-leak balance for Na(+) and K(+) in malaria-infected erythrocytes. Am J Physiol Cell Physiol. 2001;280:C1576-1587.
87. STAINES HM, DEE BC, O'BRIEN M, LANG HJ, ENGLERT H, HORNER HA, et al. Furosemide analogues as potent inhibitors of the new permeability pathways of Plasmodium falciparum-infected human erythrocytes. Mol Biochem Parasitol. 2004a;133:315-318.
88. STAINES HM, POWELL T, THOMAS SL, ELLORY JC. Plasmodium falciparuminduced channels. Int J Parasitol. 2004b;34:665-673.
89. STAINES HM, ELLORY JC, CHIBALE K. The new permeability pathways: targets and selective routes for the development of new antimalarial agents. Comb Chem High Throughput Screen. 2005;8:81-88.
90. STRANGE K, EMMA F, JACKSON PS. Cellular and molecular physiology of volume-sensitive anion channels. Am J Physiol. 1996;270:711-730.
91. TANNEUR V, DURANTON C, BRAND VB, SANDU CD, AKKAYA C, KASINATHAN RS, et al. Purinoceptors are involved in the induction of an osmolyte permeability in malaria-infected and oxidized human erythrocytes. Faseb J. 2006;20:133-135.
92. TARAMELLI D, MONTI D, BASILICO N, PARAPINI S, OMODEO-SALE F, OLLIARO P. A fine balance between oxidised and reduced haem controls the survival of intraerythrocytic plasmodia. Parassitologia. 1999;41:205-208.
93. THOMAS SL, LEW VL. Plasmodium falciparum and the permeation pathway of the host red blood cell. Trends Parasitol. 2004;20:122-125.
94. TILLEY L, LORIA P, FOLEY M. Choloroquine and other quinoline antimalarials. In: ROSENTHAL, PJ, editor. Antimalarial chemotherapy: mechanisms of action, resistance, and new directions in drug discovery. New Jersey: Human Press Inc; 2001. p. 87-121.
95. TOYODA M, RAUSCH WD, INOUE K, OHNO Y, FUJIYAMA Y, TAKAGI K, et al. Comparison of solanaceous glycoalkaloids-evoked Ca2+ influx in different types of cultured cells. Toxicol in vitro. 1991;5:347-351.
96. TRAORE F, FAURE R, OLLIVIER E, GASQUET M, AZAS N, DEBRAUWER L, et al. Structure and antiprotozoal activity of triterpenoid saponins from Glinus oppositifolius. Planta Med. 2000;66:368-371.
97. URSOS LM, DUBAY KF, ROEPE PD. Antimalarial drugs influence the pH dependent solubility of heme via apparent nucleation phenomena. Mol Biochem Parasitol. 2001;112:11-17.
98. VERLOO P, KOCKEN CH, VAN DER WEL A, TILLY BC, HOGEMA BM, SINAASAPPEL M, et al. Plasmodium falciparum-activated chloride channels are defective in erythrocytes from cystic fibrosis patients. J Biol Chem. 2004;279:10316-10322.
99. WARBER S. Modes of action at target sites. In: KAUFMAN, PB, CSEKE, LJ, WARBER, S, DUKE, JA, BRIELMANN, HL, editors. Natural products from plants. USA: CRC Press; 1999. p. 157-181.
100. WEI N, SADRZADEH SM. Enhancement of hemin-induced membrane damage by artemisinin. Biochem Pharmacol. 1994;48:737-741.
101. WHO. The use of antimalarial drugs. Report of WHO informal consultation. Geneva: WHO; 2001. Documento WHO/CDS/RBM/2001.2033.
102. WISSING F, SANCHEZ CP, ROHRBACH P, RICKEN S, LANZER M. Illumination of the malaria parasite Plasmodium falciparum alters intracellular pH. Implications for live cell imaging. J Biol Chem. 2002;277:37747-37755.
103. WUNSCH S, SANCHEZ CP, GEKLE M, GROSSE-WORTMANN L, WIESNER J, LANZER M. Differential stimulation of the Na+/H+ exchanger determines chloroquine uptake in Plasmodium falciparum. J Cell Biol. 1998;140:335-345.
104. YAYON A, CABANTCHIK ZI, GINSBURG H. Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. Embo J. 1984;3:2695-2700.
105. ZHENG J, RAMIREZ VD. Rapid inhibition of rat brain mitochondrial proton F0F1-ATPase activity by estrogens: comparison with Na+, K+ -ATPase of porcine cortex. Eur J Pharmacol. 1999;368:95-102.
106. ZIEGLER HL, STAERK D, CHRISTENSEN J, HVIID L, HAGERSTRAND H, JAROSZEWSKI JW. in vitro Plasmodium falciparum drug sensitivity assay: inhibition of parasite growth by incorporation of stomatocytogenic amphiphiles into the erythrocyte membrane. Antimicrob Agents Chemother. 2002;46:1441-1446.
107. ZIEGLER HL, FRANZYK H, SAIRAFIANPOUR M, TABATABAI M, TEHRANI MD, BAGHERZADEH K, et al. Erythrocyte membrane modifying agents and the inhibition of Plasmodium falciparum growth: structure-activity relationships for betulinic acid analogues. Bioorg Med Chem. 2004;12:119-127.